Voglibose IP 0.3 mg Metformin Hydrochloride IP 500 mg (In extended release form) tab
62.0 आईएनआर/Strip
उत्पाद विवरण:
- दिखावट Pink and white capsules
- घुलनशीलता water
- सामग्रियां
- फ़ीचर ER tablet for controlled release of active ingredients
- शेल्फ लाइफ वर्ष
- स्टोरेज निर्देश
- अधिक देखने के लिए क्लिक करें
X
मूल्य और मात्रा
- 100
उत्पाद की विशेषताएं
- Pink and white capsules
- water
- ER tablet for controlled release of active ingredients
- वर्ष
व्यापार सूचना
- प्रति महीने
- दिन
उत्पाद वर्णन
Description
- Each Uncoated Bilayered Tablet Contains: Voglibose IP 0.3 mg Metformin Hydrochloride IP 500 mg (In extended release form)
Doses
- As Directed by Physician
Indication
- Treatment of type 2 diabetes mellitus, which occurs when the level of glucose (sugar) in the blood becomes higher than normal.
Optimized Dual-Action Diabetes Management
This medication combines Voglibose and extended release Metformin Hydrochloride to offer comprehensive glycemic control. Voglibose slows carbohydrate absorption, while Metformin helps lower blood glucose production and improves insulin sensitivity, making them an effective duo for managing type 2 diabetes.
Extended Release for Sustained Efficacy
The extended release (ER) formulation ensures that Metformin is gradually released into the body, maintaining steady blood levels and reducing the risk of side effects commonly associated with immediate-release forms. This allows for better compliance and consistent management of your condition.
Easy Storage & Distinct Appearance
These pink and white capsules are easy to identify and designed for convenient storage. Thanks to their water solubility and two-year shelf life, they can be safely kept in a cool place without significant risk of degradation.
FAQ's of Voglibose IP 0.3 mg Metformin Hydrochloride IP 500 mg (In extended release form) tab:
Q: How should Voglibose IP 0.3 mg and Metformin Hydrochloride ER 500 mg tablets be taken for best results?
A: It is recommended to take the medication as prescribed by your physician, usually with meals to minimize gastrointestinal discomfort. The extended release formulation should not be crushed or chewed; swallow the tablets whole with water.Q: What is the main benefit of the extended release (ER) formulation in these tablets?
A: The ER formulation provides controlled and gradual release of Metformin Hydrochloride, helping maintain more stable blood glucose levels throughout the day and reducing the likelihood of side effects due to high peak concentrations.Q: When can I expect to notice improvement in blood glucose control after starting this medication?
A: While individual responses vary, most users start to observe better glycemic control within a few days to weeks of consistent use, provided the medication is combined with an appropriate diet and exercise regimen.Q: Where should these tablets be stored to maintain their efficacy?
A: Keep the tablets in a cool place away from direct sunlight and moisture. Proper storage is crucial to ensuring the medication remains effective throughout its shelf life of two years.Q: What is the process for supplying or distributing Voglibose and Metformin tablets in India?
A: These tablets are available through a network of dealers, distributors, wholesalers, and retailers across India. Interested parties, including fabricators, exporters, importers, manufacturers, producers, service providers, and suppliers, can procure the product based on regulatory protocols and supply chain requirements.Q: Can these pink and white capsules be dissolved in water for ingestion?
A: Although the tablets are water-soluble, they are designed to be taken whole to ensure sustained release. Dissolving or crushing them may alter the release mechanism and reduce effectiveness.Q: What ingredients are contained in these tablets?
A: Each tablet contains Voglibose HCl IP 0.3 mg and Metformin Hydrochloride IP 500 mg in an extended release formulation, combining two well-established anti-diabetic agents for optimal efficacy.Tell us about your requirement
Price: Â
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
मोबाइल number
Email
मधुमेह विरोधी दवा अन्य उत्पाद
संपर्क करें
- बी नंबर 673, ब्लॉक-ई-673, डीएसआईआईडीसी, औद्योगिक क्षेत्र, नरेला,दिल्ली - 110040, भारत
- फ़ोन : +917971671193 PIN:( 207 )
देखभाल सूत्रीकरण लैब्स प्राइवेट लिमिटेड
GST : 07AAECC3106E1Z9
- श्री नवीन कुमार जिंदल (निदेशक)
- मोबाइल : 917971671193 PIN:( 207 )
- जांच भेजें
- Mr. Naveen Kumar Jindal (Director)
मोबाइल : +917827946686, +919810255103
जांच भेजें हमारे उत्पाद
- हर्बल उत्पाद
- यूरोलॉजी और नेफ्रोलॉजी चिकित्सा
- स्तंभन दोष की दवा
- फार्मास्युटिकल इंजेक्शन
- एंडोक्रिनोलॉजी टैबलेट
- ऑन्कोलॉजी चिकित्सा
- नेत्र चिकित्सा
- स्त्री रोग चिकित्सा
- दर्द निवारक दवा
- एचआईवी और एड्स की दवा
- सामान्य दवा
- संक्रमण रोधी दवा
- प्रसाधन उत्पाद
- मधुमेह विरोधी दवा
- श्वसन औषधि
- कार्डिक केयर मेडिसिन
- आयुर्वेदिक उत्पाद
- तंत्रिका संबंधी चिकित्सा
- एंटी एलर्जिक दवा
- त्वचा विज्ञान चिकित्सा
- आर्थोपेडिक चिकित्सा
- गैस्ट्रोएंटेरोलॉजिकल मेडिसिन
- शाकाहारी धुलाई
|
जांच भेजें
CARE FORMULATION LABS PRIVATE LIMITED
सर्वाधिकार सुरक्षित.(उपयोग की शर्तें)
इन्फोकॉम नेटवर्क प्राइवेट लिमिटेड . द्वारा विकसित एवं प्रबंधित
इन्फोकॉम नेटवर्क प्राइवेट लिमिटेड . द्वारा विकसित एवं प्रबंधित
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese